Wnt / Hedgehog / Notch
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #9331S | 100 μL | 57,000 | |
|
| #9331L | 300 μL | 137,000 | |
GSK3抗体製品一覧
9331 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
9331:
-
IHC / Paraffin
Western Blotting
下記ステップについては、データシートの右側もあわせてご参照ください。
IHC-P: 抗体希釈液 / 抗原賦活化
| 用途(希釈倍率) | |
| ウェスタンブロッティング(1:1,000)、免疫組織染色(パラフィン)(1:50) |
| 種交差性 | |
| ヒト、マウス、ラット、サル、キイロショウジョウバエ、ゼブラフィッシュ |
| 特異性・感度 | |
| 内在性レベルのSer21 がリン酸化されたGSK-3α タンパク質およびSer9 がリン酸化されたGSK-3β タンパク質を検出します。 |
| 検出タンパク質の分子量 | |
| 46 kDa、51 kDa |
| 使用抗原 | |
| ヒトのGSK-3α タンパク質の配列(合成リン酸化ペプチド) |
Western Blotting

Western blot analysis of extracts from 293 cells, untreated or insulin treated for the indicated times, using Phospho-GSK-3alpha/beta (Ser21/9) Antibody (upper) or GSK-3beta Antibody #9332 (lower).
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma, showing nuclear and cytoplasmic localization, using Phospho-GSK-3alpha/beta (Ser21/9) Antibody.
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma, untreated (left) or lambda phosphatase-treated (right), using Phospho-GSK-3alpha/beta (Ser21/9) Antibody.
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma, using Phospho-GSK-3alpha/beta (Ser21/9) Antibody in the presence of control peptide (left) or antigen-specific peptide (right).
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded LNCaP cells, untreated (left) or LY294002-treated (right), using Phospho-GSK-3alpha/beta (Ser21/9) Antibody. Note the reduction of stain in the LY294002-treated cells.
Glycogen synthase kinase-3 (GSK-3) was initially identified as an enzyme that regulates glycogen synthesis in response to insulin (1). GSK-3 is a ubiquitously expressed serine/threonine protein kinase that phosphorylates and inactivates glycogen synthase. GSK-3 is a critical downstream element of the PI3K/Akt cell survival pathway whose activity can be inhibited by Akt-mediated phosphorylation at Ser21 of GSK-3α and Ser9 of GSK-3β (2,3). GSK-3 has been implicated in the regulation of cell fate in Dictyostelium and is a component of the Wnt signaling pathway required for Drosophila, Xenopus, and mammalian development (4). GSK-3 has been shown to regulate cyclin D1 proteolysis and subcellular localization (5).
-
Welsh, G.I. et al. (1996) Trends Cell. Biol. 6, 274-279.
-
Srivastava, A.K. and Pandey, S.K. (1998) Mol. Cell. Biochem. 182, 135-141.
-
Cross, D.A. et al. (1995) Nature 378, 785-789.
-
Nusse, R. (1997) Cell 89, 321-323.
-
Diehl, J.A. et al. (1998) Genes Dev. 12, 3499-3511.
- Armstrong, J. L. et al. (2001) Regulation of glycogen synthesis by amino acids in cultured human muscle cells. J. Biol. Chem. 276, 952-956. Applications: Western Blotting
- Fasshauer, M. et al. (2000) Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J. Biol. Chem. 275, 25494-25501. Applications: Western Blotting
- Zheng, W. H. et al. (2000) Insulin-like growth factor-1-induced phosphorylation of the Forkhead family transcription factor FKHRL1 Is mediated by Akt kinase in PC12 cells. J. Biol. Chem. 275, 39152-39158. Applications: Western Blotting
- Peyssonnaux, C. et al. (2000) Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways. Mol. Cell. Biol. 20, 7068-7079. Applications: Western Blotting
- Allard, D. et al. (2008) J Biol Chem 283, 19739-47. Applications: Western Blotting
- Popkie, A.P. et al. (2010) J Biol Chem 285, 41337-47. Applications: Western Blotting
- Fonseca, B.D. et al. (2011) J Biol Chem 286, 27111-22. Applications: Western Blotting
- Ohtani, M. et al. (2008) Blood 112, 635-43. Applications: Western Blotting
- Kitamura, T. et al. (2008) Nat Cell Biol 10, 329-37. Applications: Western Blotting